NeOnc Technologies Holdings is trading 5.01% down at $2.84 amid weakness in biotechnology and broader markets. - The supplied sector context reports XBI down 2.50%. - No new company announcement was found for October 7; FDA meeting coverage concerns a previously announced November 17 meeting, not a fresh catalyst. - Available evidence points to sector and risk-off pressure rather than a company-specific event; trading volume details were not verified.